• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HeartLogic与TriageHF算法在心力衰竭远程监测中的比较诊断效能:一项队列研究

Comparative Diagnostic Efficacy of HeartLogic and TriageHF Algorithms in Remote Monitoring of Heart Failure: A Cohort Study.

作者信息

Ledesma Oloriz David, García Iglesias Daniel, di Massa Pezzutti Rodrigo Ariel, López Iglesias Fernando, Rubín López José Manuel

机构信息

Arrhythmia Unit, Cardiology Department, Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.

Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), 33011 Oviedo, Spain.

出版信息

J Cardiovasc Dev Dis. 2025 May 31;12(6):209. doi: 10.3390/jcdd12060209.

DOI:10.3390/jcdd12060209
PMID:40558644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12193614/
Abstract

INTRODUCTION

Implantable defibrillator devices (ICDs) can be used for remote monitoring of different variables, including some related to Heart Failure (HF). Two different algorithms (TriageHF and HeartLogic) arise by combining some of these variables to generate an estimation of HF decompensation risk in the following days. Until now, no other trial has evaluated both algorithms in a head-to-head comparison. The primary objective is to compare diagnostic accuracy of both algorithms in a similar cohort of patients.

MATERIAL AND METHODS

Descriptive monocentric cohort study of a series of 64 patients who have been implanted with a Medtronic or Boston Scientific ICD with the TriageHF or Heart Logic algorithm available during the period between January 2020 and June 2022, with a total of 27 patients in the HeartLogic group and 37 patients in the TriageHF group.

RESULTS

During the period of the study there were a total of 1142 alarms analyzed. There were no differences in the basal characteristics of both groups. We reported a risk alarm-patient ratio of 1.31 ± 1.89 in the HeartLogic group and of 3.32 ± 3.08 in the TriageHF group ( < 0.01). In the TriageHF group, we reported a lower specificity with (0.76), with higher sensitivity (0.97) and PPV (0.18), and similar NPV (1). Survival analysis shows no statistical differences between both algorithms in the 30 days following the alert.

CONCLUSIONS

TriageHF algorithm had higher sensibility and PPV, leading to a higher number of alerts/patients, while HeartLogic algorithm had a better specificity. These differences should be considered to optimize patient follow-ups in home monitoring.

摘要

引言

植入式除颤器设备(ICD)可用于远程监测不同变量,包括一些与心力衰竭(HF)相关的变量。通过组合其中一些变量产生了两种不同的算法(TriageHF和HeartLogic),以生成未来几天HF失代偿风险的估计值。到目前为止,尚无其他试验对这两种算法进行过直接比较。主要目的是比较这两种算法在相似患者队列中的诊断准确性。

材料与方法

对2020年1月至2022年6月期间植入美敦力或波士顿科学ICD且具备TriageHF或HeartLogic算法的64例患者进行描述性单中心队列研究,HeartLogic组共27例患者,TriageHF组共37例患者。

结果

在研究期间,共分析了1142次警报。两组的基线特征无差异。我们报告HeartLogic组的风险警报与患者比例为1.31±1.89,TriageHF组为3.32±3.08(<0.01)。在TriageHF组中,我们报告其特异性较低(0.76),敏感性较高(0.97)和阳性预测值(PPV)较高(0.18),阴性预测值(NPV)相似(1)。生存分析显示,在警报后的30天内,两种算法之间无统计学差异。

结论

TriageHF算法具有更高的敏感性和PPV,导致警报/患者数量更多,而HeartLogic算法具有更好的特异性。在优化家庭监测中的患者随访时应考虑这些差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9daa/12193614/f2087594a347/jcdd-12-00209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9daa/12193614/f2087594a347/jcdd-12-00209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9daa/12193614/f2087594a347/jcdd-12-00209-g001.jpg

相似文献

1
Comparative Diagnostic Efficacy of HeartLogic and TriageHF Algorithms in Remote Monitoring of Heart Failure: A Cohort Study.HeartLogic与TriageHF算法在心力衰竭远程监测中的比较诊断效能:一项队列研究
J Cardiovasc Dev Dis. 2025 May 31;12(6):209. doi: 10.3390/jcdd12060209.
2
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
4
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
5
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.对不同患者群体中植入式心脏复律除颤器治疗的效果和成本相关证据的综述,以及在英国背景下对这些群体的成本效益和成本效用进行建模。
Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.

本文引用的文献

1
Heart Failure Management through Telehealth: Expanding Care and Connecting Hearts.通过远程医疗进行心力衰竭管理:扩大护理范围并连接心灵。
J Clin Med. 2024 Apr 28;13(9):2592. doi: 10.3390/jcm13092592.
2
Remotely Monitored Cardiac Implantable Electronic Device Data Predict All-Cause and Cardiovascular Unplanned Hospitalization.远程监测心脏植入式电子设备数据可预测全因和心血管非计划性住院。
J Am Heart Assoc. 2022 Aug 16;11(16):e024526. doi: 10.1161/JAHA.121.024526. Epub 2022 Aug 9.
3
Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure.
多参数远程监测系统HeartLogic在心力衰竭中的临床应用
Card Fail Rev. 2022 Apr 21;8:e13. doi: 10.15420/cfr.2021.35. eCollection 2022 Jan.
4
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
5
Prevalence, incidence and survival of heart failure: a systematic review.心力衰竭的患病率、发病率和生存率:系统评价。
Heart. 2022 Aug 11;108(17):1351-1360. doi: 10.1136/heartjnl-2021-320131.
6
Remote heart failure management using the HeartLogic algorithm. RE-HEART registry.使用 HeartLogic 算法进行远程心力衰竭管理。RE-HEART 登记研究。
Rev Esp Cardiol (Engl Ed). 2022 Sep;75(9):709-716. doi: 10.1016/j.rec.2021.09.015. Epub 2021 Dec 9.
7
Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study.结合植入式除颤器的家庭监测时间趋势和基线患者风险特征预测心力衰竭住院:来自 SELENE HF 研究的结果。
Europace. 2022 Feb 2;24(2):234-244. doi: 10.1093/europace/euab170.
8
Multiparametric Implantable Cardioverter-Defibrillator Algorithm for Heart Failure Risk Stratification and Management: An Analysis in Clinical Practice.多参数植入式心脏复律除颤器算法在心力衰竭风险分层和管理中的应用:临床实践分析。
Circ Heart Fail. 2021 Oct;14(10):e008134. doi: 10.1161/CIRCHEARTFAILURE.120.008134. Epub 2021 Jun 30.
9
Clinical and economic impact of HeartLogic™ compared with standard care in heart failure patients.与标准治疗相比,HeartLogic™对心力衰竭患者的临床和经济影响。
ESC Heart Fail. 2021 Apr;8(2):1541-1551. doi: 10.1002/ehf2.13252. Epub 2021 Feb 22.
10
Prediction of worsening heart failure events and all-cause mortality using an individualized risk stratification strategy.使用个体化风险分层策略预测心力衰竭事件恶化和全因死亡率。
ESC Heart Fail. 2020 Dec;7(6):4277-4289. doi: 10.1002/ehf2.13077. Epub 2020 Oct 28.